Ligliptin for treatment of type 2 diabetes mellitus with early renal injury: Efficacy and impact on endogenous hydrogen sulfide and endothelial function

Table 2 Comparison of blood glucose levels before and after treatment between the two groups

	Ligliptin treatment group	Gliquidone treatment group	P value
Number of cases	54	56
FBG (mmol/L)
Before treatment	8.90 (1.28)	8.78 (1.30)	0.627
After treatment	7.13 (1.05)a	7.15 (1.01)a	0.919
2hPG (mmol/L)
Before treatment	12.05 (1.43)	12.10 (1.51)	0.859
After treatment	8.15 (1.65)a	8.20 (1.70)a	0.876
HbA1c (%)
Before treatment	7.99 (1.40)	7.94 (1.31)	0.847
After treatment	7.00 (1.22)a	6.93 (1.18)a	0.760

^aP < 0.05 vs before treatment. FBG: Fasting blood glucose; 2hPG: 2 h blood glucose; HbA1c: Glycated hemoglobin.